The possibility that dietary fish oil supplementation may benefit pati
ents with hypercalciuric urolithiasis by decreasing calcium excretion
and enhancing protective mechanisms has been studied in rats and human
s. In experiments on rats in metabolic cages, fish oil inhibited exper
imental nephrocalcinosis induced by intraperitoneal calcium gluconate.
There were no significant changes in urinary biochemistry. In a clini
cal study on 18 hypercalciuric recurrent stone patients fish oil signi
ficantly decreased urinary calcium excretion. This effect was accompan
ied by decreases in the excretion of magnesium and citrate. Oxalate ex
cretion and urinary fibrinolytic activity were unchanged. Overall, fis
h oil had a limited impact on the risk profile for recurrent urolithia
sis.